About Andy Carter
Andy Carter is a co-founder, chief technology officer, and director at Tetrous.
Andy Carter first appears on SEC filings in 2023.
Experience
This experience comes from Andy Carter's profile and from SEC filings. For roles taken from filings, the years are when the filings name Andy Carter in the role, so the role may have started earlier or lasted longer.
Tetrous, Inc. Current
Co-founder, Chief Technology Officer, and Director
Founder and Director (2019 – Present)
2019 – Present · Sherman Oaks, CA
Bone-fiber implants for surgeons repairing tendons and ligaments.
PM
Prince of Wales Clinical School - UNSW Medicine Current
Adjunct Associate Professor
2018 – Present
DI
DermOQ, Inc. Current
Founder and Chief Technology Officer
2017 – Present
AB
Accent Biomedical Current
President
2010 – Present
TI
TheraCell, Inc
Chief Technology Officer
2011 – 2022
AT
Anika Therapeutics
Chief Technology Officer
2008 – 2010
SI
Spine Wave, Inc.
VP & General Manager
2003 – 2008
SE
Smith & Nephew Endoscopy
Group Director of R&D (2000 – 2003)
Programme Manager Orthopaedics and Arthroscopy (1982 – 2000)
1982 – 2003
Key Colleagues at Startups
The people Andy Carter works with at each company, as listed on that company's latest Form D.
Tetrous, Inc. · Form D, Apr 22, 2026
GA
Gunnar Andersson
Director
Nikhil Verma
Director
MM
Matthew Muscio
Director
Frank Philips
Director
John Bojanowski
Chief Commercial Officer and Director
Simon Berry
Director
Jan Iwanczyk
Director
Bradley Patt
Co-founder, CEO, and Chairman of the Board